CD155, an onco-immunologic molecule in human tumors

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• CD155, also known as poliovirus receptor (PVR) or necl-5, is an immunoglobulin-like adhesion molecule.
• It plays roles in cell motility and immune responses, acting as a receptor for poliovirus.
• CD155 is typically lowly expressed in normal tissues but frequently overexpressed in various human cancers.

Purpose of the Study:

• To investigate the role of CD155 in tumor progression and immunity.
• To evaluate CD155 as a potential therapeutic target in cancer treatment.

Main Methods:

• The abstract does not specify methods used.
• Analysis of CD155 expression patterns in normal and tumor tissues.
• Review of studies on CD155's function as a ligand for immune cell receptors.

Main Results:

• CD155 overexpression is linked to enhanced tumor cell invasion, migration, tumor progression, and poor prognosis.
• CD155 acts as a ligand for both activating (CD226) and inhibitory (TIGIT, CD96) receptors on immune cells, suggesting a dual role in oncoimmunity.
• Evidence suggests CD155 overexpression can lead to tumor immune escape.

Conclusions:

• CD155 plays a significant role in cancer progression and immune evasion.
• Targeting CD155 in tumors with overexpression presents a potential therapeutic strategy for cancer treatment.